Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Arch. cardiol. Méx ; 84(2): 102-109, abr.-jun. 2014.
Artículo en Español | LILACS | ID: lil-732014

RESUMEN

La proliferación de los miocitos que forman parte de los ventrículos cardíacos del mamífero adulto ha sido descartada por algunos investigadores con el argumento de que estas células están diferenciadas en forma terminal; sin embargo, este dogma ha sido puesto en duda a partir de los hallazgos de otros investigadores quienes han observado que estos miocitos pueden presentar los procesos necesarios para la proliferación, es decir síntesis de ADN, mitosis y citocinesis, cuando el miocardio se daña en forma experimental con estrategias de tipo farmacológico o quirúrgico, o debido a condiciones patológicas relacionadas con el sistema cardiovascular. Esta revisión integra algunos de los trabajos disponibles en la literatura que han evaluado la síntesis del ADN, mitosis y citocinesis en estas células, en el miocardio dañado, para saber si su proliferación puede ser considerada como un fenómeno factible. La revisión concluye con una reflexión sobre las perspectivas del conocimiento generado en esta área de estudio.


Proliferation of adult mammalian ventricular cardiomyocytes has been ruled out by some researchers, who have argued that these cells are terminally differentiated; however, this dogma has been rejected because other researchers have reported that these cells can present the processes necessary to proliferate, that is, DNA synthesis, mitosis and cytokinesis when the heart is damaged experimentally through pharmacological and surgical strategies or due to pathological conditions concerning the cardiovascular system. This review integrates some of the available works in the literature evaluating the DNA synthesis, mitosis and cytokinesis in these myocytes, when the myocardium is damaged, with the purpose of knowing if their proliferation can be considered as a feasible phenomenon. The review is concluded with a reflection about the perspectives of the knowledge generated in this area.


Asunto(s)
Adulto , Animales , Perros , Humanos , Ratones , Ratas , Proliferación Celular , ADN , Ventrículos Cardíacos/citología , Mitosis/fisiología , Miocitos Cardíacos/fisiología , Bromodesoxiuridina/metabolismo , Diferenciación Celular , Citocinesis , Miocitos Cardíacos/citología , Antígeno Nuclear de Célula en Proliferación/metabolismo , ARN Mensajero/metabolismo
2.
Mem. Inst. Oswaldo Cruz ; 103(6): 585-590, Sept. 2008. ilus, graf
Artículo en Inglés | LILACS | ID: lil-495733

RESUMEN

It has been demonstrated that the acute phase of Trypanosoma cruzi infection promotes several changes in the oral glands. The present study examined whether T. cruzi modulates the expression of host cell apoptotic or mitotic pathway genes. Rats were infected with T. cruzi then sacrificed after 18, 32, 64 or 97 days, after which the submandibular glands were analyzed by immunohistochemistry. Immunohistochemical analyses using an anti-bromodeoxyuridine antibody showed that, during acute T. cruzi infection, DNA synthesizing cells in rat submandibular glands were lower than in non-infected animals (p < 0.05). However, after 64 days of infection (chronic phase), the number of immunolabeled cells are similar in both groups. However, immunohistochemical analysis of Fas and Bcl-2 expression did not find any difference between infected and non-infected animals in both the acute and chronic stages. These findings suggest that the delay in ductal maturation observed at the acute phase of Chagas disease is correlated with lower expression of DNA synthesis genes, but not apoptotic genes.


Asunto(s)
Animales , Masculino , Ratas , Enfermedad de Chagas/patología , ADN , Glándula Submandibular/parasitología , Apoptosis , Bromodesoxiuridina/metabolismo , Enfermedad de Chagas/metabolismo , Proteína Ligando Fas/biosíntesis , Inmunohistoquímica , /biosíntesis , Glándula Submandibular/metabolismo , Glándula Submandibular/patología , Factores de Tiempo
3.
Experimental & Molecular Medicine ; : 98-108, 2008.
Artículo en Inglés | WPRIM | ID: wpr-77109

RESUMEN

Human embryonic stem cells (hESCs) are considered to be able to stably maintain their characteristics in vitro for prolonged periods, but we had previously encountered changes in proliferative ability and differentiation potential during extended culture of hESCs. Therefore, we investigated the proliferative ability and differentiation potential of hESCs during long-term culture. The hESCs, SNUhES3, were used to analyze population-doubling time, proliferation rate and differentiation potential. We classified hESCs into three groups according to culture period. Ten colonies of hESCs for each group were daily measured colony area and population-doubling time was assessed by the changes of colony area. Proliferation rate of hESCs was measured by 5-bromo-2'-deoxyuridine (BrdU) assay and telomerase activity. To evaluate differentiation potentials for hESCs, expression levels of undifferentiated and/or differentiated hESCs markers were examined by FACS, RT-PCR and immunostaining. Population-doubling time of early passage hESCs was longer than those of middle or late passage. Proliferative ability of hESCs was accelerated depending on culture periods. Cellular morphologies and the expression level of each three germ layer markers were obviously different from each passage of reattached embryoid bodies (EBs) after spontaneous differentiation. Differentiated cells of late passage expressed higher levels of undifferentiated markers such as Oct4 and SSEA4 than those of early and middle passage. But differentiated cells of early and middle passage expressed higher level of differentiated state markers, Nestin (ectoderm), Brachyury (mesoderm), HNF3beta (endoderm). From these results, it can be inferred that hESCs show higher proliferative abilities and reduced differentiation potentials as the passage number increased. Therefore, we conclude that early passage hESCs could be more suitable than middle and late passage hESCs in differentiation studies.


Asunto(s)
Humanos , Biomarcadores/metabolismo , Bromodesoxiuridina/metabolismo , Diferenciación Celular , Proliferación Celular , Células Cultivadas , Ciclinas/metabolismo , Proteínas de Unión al ADN/genética , Células Madre Embrionarias/citología , Citometría de Flujo , Regulación de la Expresión Génica , Proteínas de Homeodominio/genética , Cariotipificación , Factor 3 de Transcripción de Unión a Octámeros/genética , Telomerasa/metabolismo , Factores de Tiempo
4.
Journal of Veterinary Science ; : 219-222, 2007.
Artículo en Inglés | WPRIM | ID: wpr-200809

RESUMEN

There has been no study aimed at directly determiningof the periods of Sertoli cell proliferation in birds evendomestic fowl. The aims of this study were to observe thecessation of post-hatching mitotic proliferation of Sertolicells in domestic fowl, and to determine the volumedensity of Sertoli and germ cells during this period. Atotal of 50 Leghorn chicks were used in this study. Thetestes sections of the animals were immunostained withBrdU to observe the proliferation of cells from one to 10weeks of age. The volume density of the Sertoli and germcells were determined using the standard point countingmethod. The volume density of the germ cell nuclei wasinitially less than that of the Sertoli cells but the volumedensity converged by week 6, and remained relativelyconstant until the commencement of meiosis. Clearlabeling of Sertoli and germ cells was observed from week1 to week 7. The only those cells still labeled after 8 weekswere germ cells, indicating that Sertoli cell proliferationhad ceased. Therefore, it is recommended that anyresearch into the testes of domestic fowl should considerthe cessation of Sertoli cell proliferation by approximately8 weeks.


Asunto(s)
Animales , Masculino , Bromodesoxiuridina/metabolismo , Diferenciación Celular/fisiología , Procesos de Crecimiento Celular/fisiología , Pollos/fisiología , Histocitoquímica/veterinaria , Mitosis/fisiología , Células de Sertoli/citología , Espermatocitos/citología , Testículo/citología
5.
Experimental & Molecular Medicine ; : 557-562, 2004.
Artículo en Inglés | WPRIM | ID: wpr-145924

RESUMEN

p21Cip/WAF1, an important regulator of cell proliferation, is induced by both p53- and extracellular signal regulated kinase (ERK) pathways. The induction of p21Cip/WAF1 occurs by prolonged activation of the ERKs caused by extracellular stimuli, such as zinc. However, not all the cells appeared to respond to ERK pathway dependent p21Cip/WAF1 induction. Here we investigated the cause of such difference using colorectal cancer cells. p21Cip/WAF1 induction and concomitant reduction of bromodeoxyuridine (BrdU) incorporation were observed by zinc treatment within HT-29 and DLD-1. However, HCT-116 cells with high endogenous p21Cip/WAF1 levels did not show any additional increment of p21Cip/WAF1 levels by zinc treatment and did maintain high BrdU incorporation level. The p21Cip/WAF1 induction by zinc depended upon prolonged activation of extracellular signal regulated kinase (ERK) was not observed in HCT-116 cells. The percentage of BrdU positive cells was 50% higher in p21Cip/WAF1 -/- HCT-116 cells compared to p21Cip/WAF1 +/+ HCT- 116 cells, and no cells induced p21Cip/WAF1 incorporated BrdU in its nucleus, yet confirming the importance of p21Cip/WAF1 induction in anti- proliferation. These results again support that p21Cip/WAF1 induction is a determinant in the regulation of colonic proliferation by the ERK pathway.


Asunto(s)
Humanos , Bromodesoxiuridina/metabolismo , Proteínas de Ciclo Celular/metabolismo , Línea Celular Tumoral , Proliferación Celular , Neoplasias Colorrectales/enzimología , Activación Enzimática , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Flavonoides/farmacología , Inhibidores de Proteínas Quinasas/farmacología , Transducción de Señal/efectos de los fármacos , Zinc/farmacología
6.
Experimental & Molecular Medicine ; : 361-366, 2002.
Artículo en Inglés | WPRIM | ID: wpr-203700

RESUMEN

Repetitive low dose thioacetamide (TA) treatment of hepatocytes was found to induce cells in G2 arrest. In the present study, an attempt was made to investigate alterations in expression of cell cycle regulators after G1 progression in the same repetitive low dose TA treated hepatocytes system and to define the determinators involved in G2 arrest. TA was daily administered intraperitoneally, with a dose of 50 mg/kg for 7 days. Expression levels of cyclin E and CDK2 were similar, increased at day 1 and reached a peak at day 2. And they recycled from day 3 reaching a second peak at day 5. Expression level of cyclin A was similar to p27(Kip1) and p57(Kip2) but not to CDK2 and increased to a peak level at day 2. Expression levels of cyclin B1 and cdc2 were similar although the cyclin B1 level was generally low, decreased from day 1 to basal levels at day 3 and persisted at a low level till day 7. The expression level of cyclin G1 was similar to p53 that peaked at day 3 and again at day 6 elevated over basal level. BrdU-labeled hepatocytic nuclei increased from 12 h, reached a peak at day 2, then decreased, and were not detectable from day 6. The number of PCNA-labeled nuclei increased immediately, peaked at day 2, and maintained till day 7. These results suggest that G2 arrest induced by repeated TA treatment might be p53-dependent, via activation of cyclin G1, rather than inhibition of cyclin B1- cdc2 complex, and inhibitors holding S phase progression might be p27(Kip1) and p57(Kip2).


Asunto(s)
Animales , Masculino , Ratas , Bromodesoxiuridina/metabolismo , Proteína Quinasa CDC2/efectos de los fármacos , Quinasas CDC2-CDC28 , Ciclo Celular/efectos de los fármacos , Proteínas de Ciclo Celular/efectos de los fármacos , Quinasas Ciclina-Dependientes/antagonistas & inhibidores , Ciclinas/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Fase G1/efectos de los fármacos , Hígado/efectos de los fármacos , Proteínas Nucleares/efectos de los fármacos , Antígeno Nuclear de Célula en Proliferación/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Ratas Sprague-Dawley , Tioacetamida/administración & dosificación , Proteínas Supresoras de Tumor/efectos de los fármacos
7.
Indian J Exp Biol ; 1996 Dec; 34(12): 1237-40
Artículo en Inglés | IMSEAR | ID: sea-60760

RESUMEN

A non-radioactive, thymidine analogue-bromodeoxyuridine (Brdu), derivative of uridine has been used for incorporation in DNA in culture of P. falciparum at various dosages and at different time period. Parasite growth rate and effect of chloroquine in culture were monitored by microscopic observation of stained smears and incorporation of Brdu molecules were visualized by immunofluorescence and measured by enzyme immuno assay using anti-Brdu. Uptaking of Brdu in parasite is slower unlike tumour cells. A positive correlation between parasite growth and Brdu uptake measurement by ELISA has been observed.


Asunto(s)
Animales , Antimaláricos/farmacología , Bromodesoxiuridina/metabolismo , Cloroquina/farmacología , ADN Protozoario/metabolismo , Ensayo de Inmunoadsorción Enzimática , Técnicas para Inmunoenzimas , Plasmodium falciparum/efectos de los fármacos
8.
Journal of Korean Medical Science ; : 16-20, 1994.
Artículo en Inglés | WPRIM | ID: wpr-189276

RESUMEN

The proliferative activity of human gastric carcinoma was measured by means of in vitro incorporation of the thymidine analogue, 5-bromo-2'-deoxyuridine (BrdU), into the newly-synthesized DNA of fresh tumors and immunohistochemical staining of proliferating cell nuclear antigen (PCNA) using avidin-biotin peroxidase method. Eighty-two cases of surgically resected human gastric carcinomas consisting of 18 various histologic types were subjected to study. The mean BrdU labelling index (LI) and PCNA LI were 22.9% and 39.1%, respectively. The correlation between BrdU LI and PCNA LI was statistically significant (correlation coefficient mu = 0.61334, p = 0.0001). We concluded that immunohistochemical staining for PCNA may become a practical method instead of in vitro or in vivo BrdU labeling to assess the proliferation fraction of the gastric cancer patient.


Asunto(s)
Humanos , Anticuerpos Monoclonales , Antígenos de Neoplasias/metabolismo , Bromodesoxiuridina/metabolismo , Carcinoma/metabolismo , División Celular , Replicación del ADN , ADN de Neoplasias/biosíntesis , Técnicas para Inmunoenzimas , Proteínas Nucleares/metabolismo , Antígeno Nuclear de Célula en Proliferación , Neoplasias Gástricas/metabolismo , Células Tumorales Cultivadas
9.
Yonsei Medical Journal ; : 265-271, 1992.
Artículo en Inglés | WPRIM | ID: wpr-54331

RESUMEN

The bromodeoxyuridine (BrdU) labeling study provides valuable cell kinetic information for individual tumors that could suggest the prognosis of each patient who had a tumor. Recently, a monoclonal antibody against the proliferating cell nuclear antigen (PCNA or cyclin), a nuclear protein expressed in proliferating cells, was developed which could be used on formalin fixed, paraffin embedded tissue. The purpose of this study was to compare the cell kinetic data obtained by the BrdU labeling study and the PCNA method in the same patient. The relationship between labeling indices of BrdU incorporated into S-phase and PCNA expressed by cycling cells was investigated in 31 patients with brain tumors. Both of the labeling indices showed good correlation with histological grade of the tumor. The values of the PCNA labeling index (LI) were parallel but higher than those of the BrdU LI, and the relation PCNA LI = 2.2 x BrdU LI + 0.8 (r2 = 0.86) was obtained. The results of this study show that PCNA could replace the BrdU method for identifying the proliferating cells, and the major advantages of PCNA method is that it could be done without any pretreatment and avoid injection of the teratogenic agent for diagnostic purpose.


Asunto(s)
Adolescente , Adulto , Anciano , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Neoplasias Encefálicas/patología , Bromodesoxiuridina/metabolismo , División Celular , Estudio Comparativo , Persona de Mediana Edad , Proteínas Nucleares/análisis , Antígeno Nuclear de Célula en Proliferación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA